6th SSO ASM Lung Track – Evolving Treatment Landscape in EGFRm+ NSCLC
Speaker: Prof John Wen-Cheng Chang
Document ID: PC-SG-101260
Dr. John Wen-Cheng CHANG recapitulates how TKIs have contributed to improved survival through generations, and how the treatment landscape is always evolving with the objective to give more time to patients.
Speaker
John Wen-Cheng Chang, MD
Attending Physician, Associate Professor
Division of Hematology-Oncology, Department of Internal Medicine,
Chang Gung Memorial Hospital-Linkou Branch
Taoyuan, Taiwan
6th SSO ASM Lung Track – Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations
Speaker: Prof John Wen-Cheng Chang